Scholars Central

Mini reviewPublished 30 Sep 2022

Rhabdomyosarcoma and Its Risk Factors in Adults

Authors: Lin Ye

Department of Cancer and Genetics, Cardiff University, USA

Journal of Orthopedic Oncology

Volume 8 · Issue 5 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Rhabdomyosarcoma (RMS) is a pediatric soft tissue sarcoma and represents a high-grade neoplasm of skeletal myoblast-like cells. A gradual improvement in understanding of physiology has helped optimize clinical care. Two main subtypes of RMS. Originally characterized by features of optical microscopy. Driven by fundamentally different molecular mechanisms, it poses a variety of clinical challenges. Curative therapies depend on control of the primary tumor. It can occur in many different anatomical locations. Combat common ailments known or suspected to be present in all cases. Refined risk stratification for children with RMS includes a variety of clinical, pathological and molecular characteristics; this information is used to guide the application of multifaceted treatments. Such treatments have historically included both cytotoxic chemotherapy and ionizing radiation or both. This introduction describes the current understanding of the epidemiology of RMS. Factors of clinical care, including disease susceptibility factors; disease mechanisms; and diagnosis. Risk-based care for newly diagnosed and recurrent disease. Prevention and treatment of late complications in survivors.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Orthopedic Oncology
  • SubjectOncology & Cancer
  • SubjectOrthopaedics
  • BylineArticles whose byline prints “Lin Ye”